stars 1 stars 2 stars 3

The mission of iMed.UL is to foster fundamental research at the interface between biology and chemistry aimed at (i) understanding the genetic and molecular basis of human diseases and (ii) improving the development of novel therapeutic agents and medicines, using a translational research approach. iMed.UL was created to fill a gap at the national level in terms of interdisciplinary teams capable of developing basic-to-applied research based on the drug discovery and development (DDD) paradigm. Some iMed.UL core groups have links to other researchers in pharmaceutical companies, thus allowing knowledge and skill transfer on drug development process. Another important mission of iMed.UL is to provide advanced training in pharmaceutical and related sciences at the post-graduate level.

iMed.UL Questions

The iMed.UL annual revenue was $2.9 billion in 2026.

10 people are employed at iMed.UL.

iMed.UL is based in Evora, Evora.

The NAICS codes for iMed.UL are [611310, 6113, 611, 61, 541, 54, 61131].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users